Knockdown of Hypoxia-Inducible Factor 1α Improved the Efficacy of Low-Dose Metronomic Chemotherapy of Paclitaxel in Human Colon Cancer Xenografts
Authors:
Open Access
- 29 August 2016
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 16 (5) , 609-619
Abstract
Low-dose metronomic chemotherapy represents a new strategy for solid tumor treatments with a strong antiangiogenic activity and few side effects. However, low-dose metronomic therapy alone is not always as effective as traditional chemotherapy on eradication of tumor. On the contrary, low-dose metronomic in some cases could stimulate tumor growth due to hypoxia of tumor cells induced during therapy. Our study aimed to investigate whether knockdown of hypoxia-inducible factor-1α expression in tumor cell could facilitate low-dose metronomic therapy with paclitaxel for human colon cancer. Human colon cancer cell line (HT-29) stably transfected with specific short hairpin RNAs silencing hypoxia-inducible factor-1α exhibited marked attenuation of hypoxia-induced expression of the target genes such as vascular endothelial growth factor, glucose transporter 1, and P-glycoprotein. Compared with HT-29-c xenograft tumor model established by subcutaneous injection of HT-29 cells stably transfected with scrambled control short hairpin RNA, HT-29-ih xenograft tumor model showed more significant and long-lasting antitumor responses of empirical metronomic paclitaxel regimens, accompanied by drastic angiogenesis decrease and neglectable toxicity. All these data indicated that the combination of paclitaxel low-dose metronomic therapy with hypoxia-inducible factor-1α knockdown might provide a potent battle against colon cancer.Keywords
This publication has 42 references indexed in Scilit:
- Combining low-dose or metronomic chemotherapy with anticancer vaccinesOncoImmunology, 2013
- Identification of high-risk factors as indicators for adjuvant therapy in stage II colon cancer patients treated at a single institutionOncology Letters, 2013
- Low-Dose Metronomic Paclitaxel Chemotherapy Suppresses Breast Tumors and Metastases in MiceCancer Investigation, 2009
- Evaluation of HIF-1 inhibitors as anticancer agentsDrug Discovery Today, 2007
- Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancerAnti-Cancer Drugs, 2006
- Hypoxia-Inducible Factor-1α Promotes Nonhypoxia-Mediated Proliferation in Colon Cancer Cells and XenograftsCancer Research, 2006
- Establishment and properties of fetal dermis-derived mesenchymal stem cell lines: plasticity in vitro and hematopoietic protection in vivoBone Marrow Transplantation, 2005
- Repopulation of cancer cells during therapy: an important cause of treatment failureNature Reviews Cancer, 2005
- Tumor hypoxia: A target for selective cancer therapyCancer Science, 2003
- Analysis of gene function in somatic mammalian cells using small interfering RNAsMethods, 2002